The Role of a Motion Sensor With Accompanying Web Application on Step Counts, Energy Balance, and Metabolic Markers in Nurses
- Conditions
- Cardiovascular Risk FactorCardiovascular Diseases
- Interventions
- Behavioral: Motion sensor
- Registration Number
- NCT04524572
- Lead Sponsor
- Ottawa Heart Institute Research Corporation
- Brief Summary
The purpose of this prospective randomized controlled trial is to explore the role of a motion sensor with accompany web application on step counts, energy balance, and metabolic markers in nurses. Additionally, eating behaviours, behavioural regulation in exercise, and mood states that may impact these parameters will also be examined.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 76
-
-
Participant must be a registered nurse with the University of Ottawa Heart Institute;
-
Participant must be 18 years of age or older;
-
Participant must be able to walk unassisted;
-
Participant is able and willing to provide informed consent.
-
- Participant is pregnant, lactating or planning to become pregnant during the study period;
- Participant is unable to read and understand English;
- Medical contraindications to exercise;
- Already using a motion sensor device to track physical activity. -
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Individual Challenge Motion sensor Participants will be able to log onto their Tractivity® Online web account at any time during the 4-week intervention phase to track their daily step counts and physical activity expenditure Team challenge Motion sensor participants will be able to log onto their Tractivity® Online web account at any time during the 4-week intervention phase to track their teams' daily step counts and physical activity expenditure in comparison to the group average of other teams. friend challenge Motion sensor Participants will be able to log onto their Tractivity® Online web account at any time during the 4-week intervention phase to track their daily step counts and physical activity expenditure in comparison to the group average of all participants randomized to the friend challenge.
- Primary Outcome Measures
Name Time Method Step counts 6 weeks during observation and 6 weeks during intervention All participants will be asked to wear a Tractivity® motion sensor device on their ankle for to assess their daily step count and physical activity energy expenditure
- Secondary Outcome Measures
Name Time Method Body Mass (kg) Screening (week 1), Observation (weeks 2-5), during the intervention (weeks 6-9), post study at week 26 and week 52 Body weight will be measured using a digital scale to the nearest 0.1 kilogram
Waist Circumference Screening (week 1), Observation (weeks 2-5), during the intervention (weeks 6-9), post study at week 26 and week 52 Waist circumference will be measured using a tape measure
Fat mass Screening (week 1), Observation (weeks 2-5), during the intervention (weeks 6-9), post study at week 26 and week 52 Fat mass will be measured using bioelectrical impedance analysis
Trial Locations
- Locations (1)
University of Ottawa Heart Institute
🇨🇦Ottawa, Ontario, Canada